September 24th, 2016

Alcester firm hails its dialysis study a success

Alcester firm hails its dialysis study a success Alcester firm hails its dialysis study a success

AN ALCESTER-based company has hailed its pioneering dialysis pilot study as a resounding success.

Representatives from Quanta Fluid Solutions Ltd announced on Monday (October 26) that the first of the group’s patients had been successfully treated with SC+ – Quanta’s portable, cartridge-based dialysis system.

Dialysis, a procedure which removes waste products and excess fluid from the blood when the kidneys stop working properly, often involves diverting blood to a machine to be cleaned.

Usually, patients have to endure dialysis by being strapped to a stationary machine but Quanta’s SC+ is designed to offer flexibility.

It is the only portable compact dialysis system capable of operating at the higher flow rates typically used by traditional machines in hospitals and clinics.

SC+ may be the first step on Quanta’s journey to developing an advanced system suitable for use in the clinic and at home.

John E. Milad, chief executive officer of Quanta, said: “This represents a important milestone for Quanta – it is a resounding validation of SC+ and its potential to improve the lives of dialysis patients.”

The pilot study, which was conducted at Nottingham University Hospitals NHS Trust, saw the first ten treatments performed on six patients over a two-week period.

Both patients and clinicians gave positive feedback with regards to the simplicity, compact size of the machine, unique cartridge concept and the quietness of SC+ when running.

Visit www.quantafs.com for more information.

Comments